STL Index for: Wolf Joel
The Role of Imiquimod 3.75% Cream in the Treatment of External Genital Warts
Imiquimod 3.75% cream has recently been approved by both the FDA and Health Canada for the treatment of external genital warts. This article is an overview of EGW, phase 3 clinical trials leading to the approval of imiquimod 3.75% cream, and comparison with imiquimod 5% cream.